Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;221(6):1041-9.
doi: 10.1016/j.jamcollsurg.2015.09.005. Epub 2015 Sep 15.

Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection

Affiliations

Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection

Bas Groot Koerkamp et al. J Am Coll Surg. 2015 Dec.

Abstract

Background: The aim of this study was to investigate the rate and pattern of recurrence after curative intent resection of perihilar cholangiocarcinoma (PHC).

Study design: Patients were included from 2 prospectively maintained databases. Recurrences were categorized by site. Time to recurrence and recurrence-free survival (RFS) were estimated using the Kaplan-Meier method. Cox proportional hazards modeling was used to identify independent poor prognostic factors.

Results: Between 1991 and 2012, 306 consecutive patients met inclusion criteria. Median overall survival was 40 months. A recurrence was diagnosed in 177 patients (58%). An initial local recurrence was found in 26% of patients: liver hilum (11%), hepaticojejunostomy (8%), liver resection margin (8%), or distal bile duct remnant (2%). An initial distant recurrence was observed in 40% of patients: retroperitoneal lymph nodes (14%), intrahepatic away from the resection margin (13%), peritoneum (12%), and lungs (8%). Only 18% of patients had an isolated initial local recurrence. The estimated overall recurrence rate was 76% at 8 years. After a recurrence-free period of 5 years, 28% of patients developed a recurrence in the next 3 years. Median RFS was 26 months. Independent prognostic factors for RFS were resection margin, lymph node status, and tumor differentiation. Only node-positive PHC precluded RFS beyond 7 years.

Conclusions: Perihilar cholangiocarcinoma will recur in most patients (76%) after resection, emphasizing the need for better adjuvant strategies. The high recurrence rate of up to 8 years justifies prolonged surveillance. Only patients with an isolated initial local recurrence (18%) may have benefited from a more extensive resection or liver transplantation. Node-positive PHC appears incurable.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative probability of recurrence (local or distant) after curative intent resection for perihilar cholangiocarcinoma with number of patients at risk. (A) All patients; (B) margin wide, narrow, or positive, p=0.002; (C) N0 (node-negative with at least 4 evaluated lymph nodes), Nx (node-negative with less than 4 evaluated lymph nodes), vs N1 (node-positive), p<0.001; (D) well versus moderately or poorly differentiated tumor, p<0.001.
Figure 1
Figure 1
Cumulative probability of recurrence (local or distant) after curative intent resection for perihilar cholangiocarcinoma with number of patients at risk. (A) All patients; (B) margin wide, narrow, or positive, p=0.002; (C) N0 (node-negative with at least 4 evaluated lymph nodes), Nx (node-negative with less than 4 evaluated lymph nodes), vs N1 (node-positive), p<0.001; (D) well versus moderately or poorly differentiated tumor, p<0.001.
Figure 1
Figure 1
Cumulative probability of recurrence (local or distant) after curative intent resection for perihilar cholangiocarcinoma with number of patients at risk. (A) All patients; (B) margin wide, narrow, or positive, p=0.002; (C) N0 (node-negative with at least 4 evaluated lymph nodes), Nx (node-negative with less than 4 evaluated lymph nodes), vs N1 (node-positive), p<0.001; (D) well versus moderately or poorly differentiated tumor, p<0.001.
Figure 1
Figure 1
Cumulative probability of recurrence (local or distant) after curative intent resection for perihilar cholangiocarcinoma with number of patients at risk. (A) All patients; (B) margin wide, narrow, or positive, p=0.002; (C) N0 (node-negative with at least 4 evaluated lymph nodes), Nx (node-negative with less than 4 evaluated lymph nodes), vs N1 (node-positive), p<0.001; (D) well versus moderately or poorly differentiated tumor, p<0.001.

References

    1. Edge SB. AJCC Cancer Staging Manual. 7th. New York, USA: Springer; 2010.
    1. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234:507–517. discussion 517–519. - PMC - PubMed
    1. Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbeck's Arch Surg / Deutsche Gesellschaft fur Chirurgie. 2014;399:693–705. - PubMed
    1. Chen XP, Lau WY, Huang ZY, et al. Extent of liver resection for hilar cholangiocarcinoma. Br J Surg. 2009;96:1167–1175. - PubMed
    1. Dumitrascu T, Chirita D, Ionescu M, Popescu I. Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome. J Gastrointest Surg. 2013;17:913–924. - PubMed

Publication types